Journal of Molecular Cancer | Make your Research Reachable to us!!!

Image

On behalf of the Journal of Molecular Cancer, as Editor-in-Chief, it is my distinct honour and privilege to welcome you. Journal of Molecular Cancer is a peer-reviewed and open access journal with an aim to provide rapid and reliable source of information in the mode of original articles, review articles, case reports, short communications, etc. in all areas of the field and making them freely available through online without any restrictions or any other subscriptions to researchers worldwide.

Journal of molecular cancer covers a broad spectrum of topics for study that discusses recent diagnostic innovations and promising therapeutic measures by constantly disseminating the novel drug and therapeutic discoveries such as; Antibody-Based Cancer Therapy, Gene and RNA Regulation, Chromatin Regulation, Oncogenes and Tumor Suppressors, Signal Transduction, and Cell-Cycle Regulation. Authors are invited to publish their findings and opinions in the form of research articles, review articles, short communications, case reports, letters to the editor, guidelines and techniques on all topics related to molecular cancer.

Journal of molecular cancer is an international English language, open-access online and print journal, will consider for publication original articles, short communications, case reports, letters to the editor, editorials and mini-reviews. Submissions will be assessed on their scientific validity and merit. Manuscripts are received with the understanding that they are submitted solely to Journal of molecular cancer and Medicinal Chemistry, and that none of the material contained in the manuscript has been published previously or is under consideration for publication elsewhere, excluding abstracts.

Authors can directly submit the article through online link: https://www.scholarscentral.org/submission/molecular-cancer.html

 Or as an attachment to this E-mail: molcancer@medicinaljournals.com

Regards,
Julia Gillard
Journal of Molecular Cancer
WhatsApp: +1-947-333-4405